Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study to Assess Safety, Tolerability and Immunogenicity of a Trivalent Influenza Vaccine Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Subjects

NCT00375206 is registered in ClinicalTrials.gov with PowderMed as lead sponsor.

NCT NCT00375206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study to Assess Safety, Tolerability and Immunogenicity of a Trivalent Influenza Vaccine Administered by Particle Mediated Epidermal Delivery (PMED) to Healthy Subjects
Lead sponsor
PowderMed
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2006
Completion date
January 31, 2007
Enrollment
189
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza